Boston Scientific to buy CryoCor

Interventional device developer Boston Scientific has inked a deal to buy cryoablation technology provider CryoCor of San Diego.

The Natick, MA-based firm will pay approximately $17.6 million, or $1.35 per share, for CryoCor. The acquisition follows a June 2007 development agreement between the firms to develop therapeutic technology for atrial fibrillation. The deal is expected to close this quarter.

Related Reading

Boston Scientific inks deal with Surgi-Vision, April 15, 2008

Boston Scientific loses patent suit, February 13, 2008

Cordis wins heart stent patent appeal, January 11, 2008

Boston Scientific sells two more units, January 7, 2008

Boston Scientific to spin off businesses, December 14, 2007

Copyright © 2008

Page 1 of 180
Next Page